Strategic Advisory Group of Experts:   recommendations on the use   of licensed human H5N1 influenza   vaccines in the interpandemic period.
D004196:Disease Outbreaks / Q000517:prevention & control; D006801:Humans; D053124:Influenza A Virus, H5N1 Subtype; D007252:Influenza Vaccines / Q000627:therapeutic use*; D007251:Influenza, Human / Q000517:prevention & control*; D014944:World Health Organization
D007252:Influenza Vaccines